Conducted AF-Response Study (Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation Treated With InSync III Marquis)
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 发起方
- 入组人数
- 100
- 试验地点
- 7
- 主要终点
- Amount of biventricular pacing in ON-group compared to OFF-group
研究概览
简要总结
The Medtronic InSync III Marquis Cardiac Resynchronization Therapy Defibrillator (CRT-D)-System (implantable cardioverter-defibrillator with biventricular stimulation for cardiac resynchronization) is equipped with the "Conducted-Atrial Fibrillation (AF)-Response-Algorithm (CAFR)". This algorithm is designed to maximize biventricular stimulation and thus the amount of cardiac resynchronization when atrial fibrillation occurs. The goal of the study is the evaluation of the effect of the CAFR in CRT-patients suffering from atrial fibrillation by quantification of the increase of biventricular pacing during atrial fibrillation caused by CAFR as well as the influence of the CAFR on the ventricular heart rate.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Implant of a Medtronic InSync III Marquis (7279) or later system with Conducted AF-Response
排除标准
- •Medical reasons that are adverse to participation in the study and compliance by the patient
- •Patients who are enrolled in another study or plan to be enrolled into another study
- •Pregnant patients or patients who are possibly pregnant due to an unreliable form of contraception
研究组 & 干预措施
Conducted AF-Response Algorithm (CAFR) On
CAFR: On
- Level medium
- Max. Rate: 110ppm VSR: Off
干预措施: Conducted AF-Response Algorithm (CAFR) On (Device)
Conducted AF-Response Algorithm (CAFR) Off
CAFR: Off VSR: Off
干预措施: Conducted AF-Response Algorithm (CAFR) Off (Device)
结局指标
主要结局
Amount of biventricular pacing in ON-group compared to OFF-group
时间窗: 1 month post-implant to 12 months post-implant
次要结局
- Characterization of the heart failure (HF)-patient population by means of: left ventricular end systolic diameter (LVESD [mm])(Implant to 12 months post-implant)
- Influence of the conducted AF response algorithm on the ventricular heart rate during atrial fibrillation(1 month post-implant to 12 months post-implant)
- Characterization of the heart failure (HF)-patient population by means of: left atrial end diastolic diameter (LAEDD [mm])](Implant to 12 months post-implant)
- Amount of hospitalizations due to heart failure (amount and duration in days)(Implant to 12 months post-implant)
- Occurrence and evaluation of rhythm disturbances: atrial arrhythmias (atrial tachyarrhythmia [AT]/AF episodes [h/day])(Implant to 12 months post-implant)
- Occurrence and evaluation of rhythm disturbances: ventricular arrhythmias(Implant to 12 months post-implant)
- Characterization of the heart failure (HF)-patient population by means of: echocardiography [left ventricular ejection fraction (LVEF [%])(Implant to 12 months post-implant)
- Characterization of the heart failure (HF)-patient population by means of: left ventricular end diastolic diameter (LVEDD [mm])(Implant to 12 months post-implant)
- Amount of patients who will be free from AF during the study(Implant to 12 months post-implant)
- Characterization of the heart failure (HF)-patient population by means of: New York Heart Association (NYHA) classification(Implant to 12 months post-implant)
- Characterization of the heart failure (HF)-patient population by means of: 6-minute walk test(Implant to 12 months post-implant)